Atlas Merchant Capital’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Atlas Merchant Capital’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-122,400	Closed	-$1.28M	–	151
2023 Q1	$1.28M	Hold	122,400	–	–	0.19%	105
2022 Q4	$1.26M	Buy	+122,400	New	+$1.24M	0.2%	119

Atlas Merchant Capital's LVAC Position: Q2 2023 in Review

Atlas Merchant Capital sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 122,400 shares — an estimated $1.28M sold.

Atlas Merchant Capital first reported a position in LVAC in Q4 2022 and held it in 2 quarters. The position peaked at $1.28M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Atlas Merchant Capital reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Atlas Merchant Capital sold 122,400 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $1.28M.
Atlas Merchant Capital first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 2 quarters.
Atlas Merchant Capital's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $1.28M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Atlas Merchant Capital's 13F filing for Q2 2023, filed 14 Aug 2023.